Infectious cDNA (complementary deoxyribonucleic acid) clone, construction method and application of recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein)

An avian leukemia virus and an infectious technology are applied in the preparation method and application field of the virus to achieve the effect of simple and effective large-scale detection

Inactive Publication Date: 2014-02-05
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI +1
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Like DR1, the E element also exists in some sarcoma viruses. It has been reported in the literature that because the E element has a very close relationship with src, it may play a role in the tumorigenesis of ASV, but for ALV-J, the E element is only in the special Tumor-promoting effect in chicken strains

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Infectious cDNA (complementary deoxyribonucleic acid) clone, construction method and application of recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein)
  • Infectious cDNA (complementary deoxyribonucleic acid) clone, construction method and application of recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein)
  • Infectious cDNA (complementary deoxyribonucleic acid) clone, construction method and application of recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein)

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1 Construction of recombinant J subgroup avian leukosis virus infectious clone capable of expressing EGFP

[0025] method:

[0026] 1. According to the completed ALV-J HPRS-103 proviral genome sequence (GenBank: Z46390.1), the spliced ​​sequence was analyzed by MapDraw software, and it was found that XBaI and ClaI had only one site in the whole genome, The location exactly divides the whole genome into 3 segments that are close in length ( figure 1 ). Although the synthetic primers R1, F2, R2, and F3 did not introduce restriction sites, the PCR products all spanned these two single restriction sites, that is, the amplified fragments of primers F1 and R1 and the amplified fragments of F2 and R2 There are XBaI sites between the overlapping sequences. Similarly, there is a ClaI site between the overlapping sequences of the amplified fragments of primers F2 and R2 and the amplified fragments of F3 and R3. To facilitate cloning into the pBluescript II KS(+) ...

Embodiment 2

[0034] Embodiment 2 Construction of the recombinant J subgroup avian leukosis virus capable of expressing EGFP with CMV promoter

[0035] method:

[0036] 1. Use QIAGEN Plasmid Midi Kits to prepare and purify the expression vector pHPRS-103-egfp prepared in Example 1, by Lipofectctamine TM 2000 respectively mediated the transfection of about 80% of monolayer DF1 cells, and normal DF1 was used as the control, discarded the supernatant of cells 6 hours after transfection, added 2ml DMEM (containing 10% PAA fetal bovine serum) and continued in a 37°C incubator After culture, the virus was harvested 72 hours after transfection, and after repeated freezing and thawing three times, it was continuously passaged on DF1. After identification, the rescued virus was named HPRS-103-egfp ( figure 2 B).

[0037] 2. Infect DF-1 cells with HPRS-103-egfp, and use HPRS-103 parental virus as a control, extract the supernatant and precipitated RNA of the infected cells, reverse transcription...

Embodiment 3

[0041] Example 3 Application of J Subgroup Avian Leukemia Virus Expressing EGFP in Detection of Virus Neutralizing Antibodies

[0042] method:

[0043] The expression of EGFP is easy to observe under a fluorescent microscope. Taking advantage of this feature, the present invention uses the virus rescued by this invention to perform a neutralizing antibody detection test (NT-EGFP). In order to verify the feasibility, specificity and sensitivity of the method. The present invention uses 30 parts of ALV-J serum, 50 parts of field serum, 30 parts of SPF chicken serum and 3 parts of anti-IBDV, ARV, ALV-A, ALV-B and MDV serums from animal experiments. All sera were tested for immunofluorescence (NIT) using HPRS-103 in parallel while using fluorescent viruses to detect neutralizing antibodies as controls. The reciprocal of the serum dilution factor was used as the neutralization index. Use the MedCalc software to draw the curve. In the NT-EGFP test, when the neutralization index...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an infectious cDNA (complementary deoxyribonucleic acid) clone, a construction method and application of a recombinant subgroup J avian leucosis virus capable of expressing EGFP (enhanced green fluorescent protein). The infectious cDNA clone has a nucleotide sequence shown by SED ID NO.1. The infectious cDNA clone of the recombinant subgroup J avian leucosis virus capable of expressing the EGFP can be used for successfully rescuing viruses. Moreover, the rescued recombinant subgroup J avian leucosis virus capable of expressing the EGFP can not influence the replication of the virus after the insertion of extraneous source EGFP, overcomes the complexity in the conventional process of detecting the an ALV-J neutralizing antibody at the same time, and can be used for large-scale detection of the ALV-J neutralizing antibody more simply and effectively.

Description

technical field [0001] The invention relates to a recombinant J subgroup avian leukosis virus, which includes all coding genes of the J subgroup avian leukosis virus and simultaneously includes CMV and EGFP expression genes. The invention also relates to the preparation method and application of the virus. The recombinant J subgroup avian leukosis virus of the present invention can replicate well on DF-1 cells, and can be applied to high-throughput detection of J subgroup avian leukosis virus neutralizing antibodies. Background technique [0002] In 1988, the first ALV-J prototype virus, HPRS-103, was isolated from broiler chickens in the UK. Based on its host range, virus envelope interference and cross-neutralization tests, it was different from A, B, C, D, and E subgroups. Independently becoming a subgroup, HPRS-103 mainly causes various types of tumors mainly caused by myeloma in broiler chickens. In 1997, Flady reported that ALV-J infection of broiler chickens also app...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/11C12N15/85C12N7/01G01N33/68G01N33/53C12R1/93
Inventor 王笑梅高玉龙王永强祁小乐高宏雷
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap